Center for Minimally Invasive Gynecologic Surgery, Newton-Wellesley Hospital, Newton, MA.
Department of Gynecology, Lahey Hospital and Medical Center, Burlington, MA.
Am J Obstet Gynecol. 2019 Mar;220(3):259.e1-259.e11. doi: 10.1016/j.ajog.2018.10.022. Epub 2018 Oct 25.
In the setting of America's opioid epidemic, judicious postoperative opioid prescribing is important. Gynecologists lack standard guidelines about postoperative opioid prescriptions.
The objectives of the study were to describe opioid prescribing practices by a group of minimally invasive gynecologic surgeons, to measure postoperative opioid use after minimally invasive hysterectomy, and to identify preoperative factors that could predict whether a patient will be a low or high postoperative opioid user.
This was a prospective survey-based study including 125 women undergoing laparoscopic hysterectomy for benign indications at 2 community teaching hospitals. Patients were preoperatively surveyed about demographics, past medical history, and current and expected pain scores and were screened for anxiety, depression, and pain catastrophizing. At 1 and 2 weeks after surgery, patients were surveyed about their pain and pain medication use.
Ninety-eight percent of patients were prescribed an opioid for acute postoperative pain. The median opioid prescription was for 150 morphine milligram equivalents, equivalent to 20 tablets of oxycodone 5 mg, while median patient postoperative use was 37.5 morphine milligram equivalents, equivalent to 5 tablets of oxycodone 5 mg. Ninety percent of patients had leftover opioids at 2 weeks after surgery, and most leftover opioids were stored in an unsecure location. Preoperative factors that were most strongly correlated with postoperative opioid use included a history of chronic pelvic pain or endometriosis, preoperative opioid use, anxiety, depression, pain catastrophizing, preoperative pain score, anticipated postoperative pain score, and anticipated postoperative pain medication needs. A predictive calculator was developed based on these factors to help identify patients who are likely to be a high opioid user (defined as taking greater than 112.5 morphine milligram equivalents) or a low opioid user (defined as taking 37.5 morphine milligram equivalents or less).
On average, surgeons prescribed 4 times the amount of opioids than was needed for patients undergoing laparoscopic hysterectomy for acute postoperative pain control. Individualizing patients' opioid prescriptions based on preoperative risk factors could help reduce excess prescription opioids.
在美国阿片类药物流行的背景下,明智地开具术后阿片类药物处方非常重要。妇科医生缺乏关于术后阿片类药物处方的标准指南。
本研究的目的是描述一组微创妇科医生的阿片类药物处方实践,测量微创子宫切除术患者术后的阿片类药物使用情况,并确定术前因素是否可以预测患者是低剂量还是高剂量术后阿片类药物使用者。
这是一项前瞻性基于调查的研究,纳入了在 2 家社区教学医院接受腹腔镜子宫切除术的 125 名良性指征的女性患者。患者在术前接受了关于人口统计学、既往病史以及当前和预期疼痛评分的调查,并进行了焦虑、抑郁和疼痛灾难化筛查。在术后 1 周和 2 周时,患者接受了疼痛和止痛药使用情况的调查。
98%的患者开具了阿片类药物用于急性术后疼痛。中位数阿片类药物处方为 150 吗啡毫克当量,相当于 20 片 5mg 羟考酮,而中位数患者术后使用量为 37.5 吗啡毫克当量,相当于 5 片 5mg 羟考酮。术后 2 周时,90%的患者仍有剩余的阿片类药物,且大部分剩余的阿片类药物存放在不安全的地方。与术后阿片类药物使用最密切相关的术前因素包括慢性盆腔疼痛或子宫内膜异位症病史、术前阿片类药物使用、焦虑、抑郁、疼痛灾难化、术前疼痛评分、预期术后疼痛评分和预期术后止痛药需求。根据这些因素开发了一个预测计算器,以帮助识别可能是高阿片类药物使用者(定义为使用大于 112.5 吗啡毫克当量)或低阿片类药物使用者(定义为使用 37.5 吗啡毫克当量或更少)的患者。
平均而言,外科医生为接受腹腔镜子宫切除术的患者开具的阿片类药物处方量是控制急性术后疼痛所需的 4 倍。根据术前风险因素个体化患者的阿片类药物处方可以帮助减少过量的阿片类药物处方。